导航

| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 15.76% | 238/1050 |
| 近一周 | 2.24% | 16/1104 |
| 近一月 | -1.51% | 228/1102 |
| 近一季 | 34.01% | 9/1092 |
| 近半年 | 21.94% | 123/1070 |
| 近一年 | -5.39% | 674/1018 |
| 近两年 | 82.94% | 274/926 |
| 近三年 | 25.42% | 434/833 |
| 成立以来 | 36.53% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
0.36% 459/1070 |
0.35% 690/1101 |
- - |
- - |
| 2025 | 38.32% 346/1065 |
20.33% 23/1014 |
9.90% 106/1038 |
30.51% 349/1050 |
-19.86% 1034/1065 |
| 2024 | -16.76% 880/1011 |
-17.89% 937/960 |
-11.57% 906/983 |
24.66% 16/991 |
-8.02% 826/1011 |
| 2023 | -26.68% 785/952 |
-6.91% 825/880 |
-14.50% 851/895 |
3.81% 8/915 |
-11.27% 884/952 |
| 2022 | -27.19% 556/867 |
-15.83% 300/773 |
4.35% 557/806 |
-22.93% 788/845 |
7.56% 125/867 |
| 2021 | -7.90% 460/740 |
-2.20% 230/580 |
25.33% 82/659 |
-10.51% 522/704 |
-16.03% 690/740 |
| 2020 | 101.44% 30/554 |
17.07% 13/419 |
46.42% 10/466 |
-0.50% 425/517 |
18.10% 152/554 |
| 2019 | - - |
- - |
1.97% 169/1228 |
14.81% 41/390 |
7.68% 251/410 |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8316 | 54.00% |
| 招商前沿医疗保健股票C | 0.7978 | 53.53% |
| 招商医药健康产业股票 | 2.5730 | 49.25% |
| 广发医药精选股票C | 1.2923 | 40.43% |
| 广发医药精选股票A | 1.3132 | 38.48% |
| 嘉实医疗保健股票 | 2.5780 | 38.47% |
| 前海开源公共卫生股票A | 0.4690 | 37.42% |
| 前海开源公共卫生股票C | 0.4590 | 37.30% |
| 中欧医疗创新股票A | 1.6444 | 34.01% |
| 中欧医疗创新股票C | 1.5481 | 33.74% |
| 中欧医疗创新股票A VS. 东吴新产业精选股票A(580008) |